Clinical TrialID 8039

Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p

NCT05850117

Helicobacter Pylori Eradication

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8039
Evidence Id
8039
Core Evidence Id
8039
Source Clinical Trial Id
8035
Herb2 Clinical Trial Id
HBCT008035
Nct Id
NCT05850117
Title
Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p
Status
Recruiting
Phase
Study Result
No
Study Condition
Helicobacter Pylori Eradication
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin|DRUG: esomeprazole , tripotassium dicitrate bismuthate, tetracycline 500mg and metronidazole|DRUG: esomeprazole, tripotassium dicitrate bismuthate , amoxicillin and levofloxacin
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
240
Outcome Measure
the rate of Helicobacter pylori, evalute eradication outcome by 13C urea breath test, 6 week after finish study drugs
Sponsor Collaborator
Kaohsiung Medical University
Funded By
OTHER
Location
Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan
Other Id
KMUHIRB-F(I)-20190136
Start Date
2020-02-10
Primary Completion Date
2024-12-31
Completion Date
2024-12-31
First Posted
2023-05-09
Results First Posted
Last Update Posted
2023-05-09
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05850117
Title Cn
Title En
Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p
Bilingual Status
semi_complete